Literature DB >> 12454693

Pathophysiology of Peyronie's disease.

R B Moreland1, A Nehra.   

Abstract

Peyronie's disease is an inflammatory condition characterized by the formation of fibrous, noncompliant nodules in the tunica albuginea which can impede tunical expansion during penile erection, leading to deformity and bending. While the cause of this disease is thought to be due to microvascular trauma and abnormal wound healing, other hypotheses include genetic predisposition. In this review the pathophysiology of Peyronie's disease is discussed as well as current hypotheses regarding its origin.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12454693     DOI： 10.1038/sj.ijir.3900875

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN： 0955-9930            Impact factor:   2.896


  13 in total

1.  Laser Therapy for Peyronie's Disease: A Randomized Control Double-Blind Pilot Study.

Authors:  Farzad Allameh; Mohammadreza Razzaghi; Seyed Mansoor Rayegani; Morteza Fallah-Karkan; Arash Ranjbar; Amirhosein Rahavian; Atefeh Javadi; Saleh Ghiasy; Zahra Razzaghi
Journal:  J Lasers Med Sci       Date:  2019-12-01

Review 2.  The Genetic Basis of Peyronie Disease: A Review.

Authors:  Amin S Herati; Alexander W Pastuszak
Journal:  Sex Med Rev       Date:  2016-01-08

Review 3.  Collagenase Clostridium Histolyticum: A Review in Peyronie's Disease.

Authors:  Sohita Dhillon
Journal:  Drugs       Date:  2015-08       Impact factor: 9.546

4.  Development of Tough Hydrogel Phantoms to Mimic Fibrous Tissue for Focused Ultrasound Therapies.

Authors:  Yashwanth Nanda Kumar; Zorawar Singh; Yak-Nam Wang; George R Schade; Wayne Kreider; Matthew Bruce; Eli Vlaisavljevich; Tatiana D Khokhlova; Adam D Maxwell
Journal:  Ultrasound Med Biol       Date:  2022-06-10       Impact factor: 3.694

5.  The contribution of the immune system to genitourinary fibrosis.

Authors:  Karen M Doersch; Daniel Barnett; Abbie Chase; Daniel Johnston; J Scott Gabrielsen
Journal:  Exp Biol Med (Maywood)       Date:  2022-05-07

6.  A Population-Based Study of Peyronie's Disease: Prevalence and Treatment Patterns in the United States.

Authors:  Dana Britt Dibenedetti; Dat Nguyen; Laurie Zografos; Ryan Ziemiecki; Xiaolei Zhou
Journal:  Adv Urol       Date:  2011-10-23

7.  Rationale of combination therapy with antioxidants in medical management of Peyronie's disease: results of clinical application.

Authors:  Gianni Paulis; Andrea Paulis; Gennaro Romano; Davide Barletta; Andrea Fabiani
Journal:  Res Rep Urol       Date:  2017-07-20

Review 8.  Recent Pathophysiological Aspects of Peyronie's Disease: Role of Free Radicals, Rationale, and Therapeutic Implications for Antioxidant Treatment-Literature Review.

Authors:  Gianni Paulis; Gennaro Romano; Luca Paulis; Davide Barletta
Journal:  Adv Urol       Date:  2017-07-04

Review 9.  The pathophysiology of Peyronie's disease.

Authors:  Ahmed I El-Sakka; Emre Salabas; Murat Dinçer; Ates Kadioglu
Journal:  Arab J Urol       Date:  2013-08-07

10.  Structured Self-Rated Response to Iontophoresis with Verapamil and Dexamethasone in Peyronie's Disease.

Authors:  Abas Kokab; Kevan Wylie; Patricia Allen; Abhijeeth Shetty; Debbie Davies-South
Journal:  Adv Urol       Date:  2014-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.